Articles
Risk selection into supplemental private health insurance in China
Different interpretation of additional evidence for HTA by the commissioned HTA body and the commissioning decision maker in Germany: whenever IQWiG and Federal Joint Committee disagree
Patient-reported data informing early benefit assessment of rare diseases in Germany: A systematic review
Effect of pecuniary costs and time costs on choice of healthcare providers among caregivers of febrile children in rural Papua New Guinea
Quality of life in chronic conditions using patient-reported measures and biomarkers: a DEA analysis in type 1 diabetes
No hay comentarios:
Publicar un comentario